PP-8-6 Paclitaxel (P) versus doxorublcin (D) as first line chemotherapy (CT) in advanced breast cancer (ABC): A randomized trial with crossover of the EORTC-IDBBC in collaboration with EORTC-ECSG

European Journal of Cancer ◽

10.1016/0959-8049(96)84242-0 ◽

1996 ◽

Vol 32 ◽

pp. 50 ◽

Cited By ~ 1

Author(s):

P. Bruning ◽

M.J. Piccart ◽

J. Klijn ◽

T. Gamucci ◽

Z. Kusenda ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Randomized Trial ◽

Advanced Breast ◽

First Line ◽

Line Chemotherapy

Download Full-text

346 Taxol or doxorubicin as first line chemotherapy in advanced breast cancer (ABC). A prospective randomized phase II study with crossover

European Journal of Cancer ◽

10.1016/0959-8049(95)95599-2 ◽

1995 ◽

Vol 31 ◽

pp. S75 ◽

Cited By ~ 1

Author(s):

R. Paridaens ◽

P. Bruning ◽

F. Calabresi ◽

A. Awada ◽

J.A. Roy ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

First Line ◽

Randomized Phase Ii ◽

Line Chemotherapy

Download Full-text

Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer)

Annals of Oncology ◽

10.1093/annonc/mdi056 ◽

2005 ◽

Vol 16 (2) ◽

pp. 253-258 ◽

Cited By ~ 59

Author(s):

L. Del Mastro ◽

F. Perrone ◽

L. Repetto ◽

L. Manzione ◽

V. Zagonel ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Weekly Paclitaxel ◽

Breast Cancer Patients ◽

First Line ◽

Line Chemotherapy

Download Full-text

Phase I, dose-finding study of capecitabine in combination with docetaxel and epirubicin as first-line chemotherapy for advanced breast cancer

Annals of Oncology ◽

10.1093/annonc/mdf056 ◽

2002 ◽

Vol 13 (4) ◽

pp. 546-552 ◽

Cited By ~ 12

Author(s):

M. Venturini ◽

L. Del Mastro ◽

O. Garrone ◽

C. Angiolini ◽

M. Merlano ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Advanced Breast Cancer ◽

Advanced Breast ◽

Dose Finding ◽

First Line ◽

Finding Study ◽

Dose Finding Study ◽

Line Chemotherapy

Download Full-text

Randomized trial or the selective aromatase inhibitor formestane (Lentaron®) versus tamoxifen as first-line hormonal therapy in postmenopausal patients with advanced breast cancer

The Breast ◽

10.1016/0960-9776(93)90119-z ◽

1993 ◽

Vol 2 (3) ◽

pp. 198-199 ◽

Cited By ~ 3

Author(s):

R. Peréz-Carrion ◽

V. Alberola ◽

F. Calabresi ◽

R-Th. Michel ◽

R. Santos ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Randomized Trial ◽

Aromatase Inhibitor ◽

Hormonal Therapy ◽

Advanced Breast ◽

First Line

Download Full-text

Should paclitaxel be combined with epirubicin or carboplatin as first-line chemotherapy for advanced breast cancer?

Nature Clinical Practice Oncology ◽

10.1038/ncponc0079 ◽

2005 ◽

Vol 2 (2) ◽

pp. 80-81

Author(s):

Sudeep Gupta

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Advanced Breast ◽

First Line ◽

Line Chemotherapy

Download Full-text

Mitoxantrone as first-line chemotherapy in advanced breast cancer: results of a collaborative European study

Investigational New Drugs ◽

10.1007/bf00174161 ◽

1985 ◽

Vol 3 (2) ◽

pp. 139-148 ◽

Cited By ~ 13

Author(s):

H. T. Mouridsen ◽

Michael Cornbleet ◽

Robin Stuart-Harris ◽

Ian Smith ◽

Robert Coleman ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Advanced Breast ◽

European Study ◽

First Line ◽

Line Chemotherapy

Download Full-text

Phase III Randomized Trial of Droloxifene and Tamoxifen As First-Line Endocrine Treatment of ER/PgR-Positive Advanced Breast Cancer

Breast Cancer Research and Treatment ◽

10.1023/a:1015229630260 ◽

2002 ◽

Vol 73 (2) ◽

pp. 161-175 ◽

Cited By ~ 44

Author(s):

A. Buzdar ◽

D. Hayes ◽

A. El-Khoudary ◽

S. Yan ◽

P. Lønning ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Randomized Trial ◽

Advanced Breast ◽

Phase Iii ◽

Endocrine Treatment ◽

First Line

Download Full-text

Phase II, multicentre study evaluating cisplatin (P), epirubicin (E) and vinorelbine (V) as first line chemotherapy (CHT) in advanced breast cancer (ABC): A new promise

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.761 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 761-761

Author(s):

S. Barni ◽

M. T. Ionta ◽

R. Labianca ◽

A. Zaniboni ◽

A. Ardizzoia ◽

...

Keyword(s):

Breast Cancer ◽

Multicentre Study ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Advanced Breast ◽

First Line ◽

Line Chemotherapy

Download Full-text

A multicentre phase II study of docetaxel 75 mg m-2 as first-line chemotherapy for patients with advanced breast cancer: report of the Clinical Screening Group of the EORTC

British Journal of Cancer ◽

10.1038/bjc.1996.416 ◽

1996 ◽

Vol 74 (4) ◽

pp. 650-656 ◽

Cited By ~ 58

Author(s):

V Dieras ◽

◽

B Chevallier ◽

P Kerbrat ◽

I Krakowski ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

First Line ◽

Clinical Screening ◽

Multicentre Phase ◽

Line Chemotherapy

Download Full-text

29 FIRST LINE CHEMOTHERAPY WITH DOCETAXEL/GEMCITABINE/TRASTUZUMAB (GOIM 2611) IN PATIENT WITH ADVANCED BREAST CANCER HER-2 POS: A CASE REPORT OF EARLY AND PROLONGED RESPONSE

Cancer Treatment Reviews ◽

10.1016/s0305-7372(10)70055-4 ◽

2010 ◽

Vol 36 ◽

pp. S103

Author(s):

F. Riccardi ◽

M. Rizzo ◽

G. Carrillo ◽

F. De Michele ◽

S. Daniele ◽

...

Keyword(s):

Breast Cancer ◽

Case Report ◽

Advanced Breast Cancer ◽

Advanced Breast ◽

First Line ◽

Her 2 ◽

Prolonged Response ◽

Line Chemotherapy

Download Full-text